Transdermal Drug Delivery System Market Report

Transdermal Drug Delivery System Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Nov 12, 2019
  • PAGES：214
  • REPORT CODE：GMM376248
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Transdermal Drug Delivery System market was valued at 6128 Million US$ in 2018 and is projected to reach 9006 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.93% during the forecast period.

    This report presents the market size and development trends by detailing the Transdermal Drug Delivery System market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Transdermal Drug Delivery System market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Transdermal Drug Delivery System industry and will help you to build a panoramic view of the industrial development.

    Transdermal Drug Delivery System Market, By Type:

    • Electroporation

    • Radiofrequency

    • Iontophoresis

    • Microporation

    • Other

    Transdermal Drug Delivery System Market, By Application:

    • Central Nervous System (CNS)

    • Pain Management

    • Cardiovascular

    • Other

    Some of the leading players are as follows:

    • Boehringer Ingelheim GmbH

    • Watson Pharmaceuticals, Inc

    • 4P Therapeutics, LLC

    • Biogel Technology, Inc

    • Mylan Pharmaceuticals, Inc

    • Noven Pharmaceuticals, Inc.

    • Johnson & Johnson

    • Novartis AG

    • Transdermal Technologies, Inc

    • Transdermal Corp.

    • Echo Therapeutics, Inc

    • Skyepharma PLC

    • 3M Company

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Transdermal Drug Delivery System Market: Technology Type Analysis

    • 4.1 Transdermal Drug Delivery System Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Transdermal Drug Delivery System Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Electroporation

      • 4.3.2 Radiofrequency

      • 4.3.3 Iontophoresis

      • 4.3.4 Microporation

      • 4.3.5 Other

    5 Transdermal Drug Delivery System Market: Product Analysis

    • 5.1 Transdermal Drug Delivery System Product Market Share Analysis, 2018 & 2026

    • 5.2 Transdermal Drug Delivery System Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Transdermal Drug Delivery System Market: Application Analysis

    • 6.1 Transdermal Drug Delivery System Application Market Share Analysis, 2018 & 2026

    • 6.2 Transdermal Drug Delivery System Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Central Nervous System (CNS)

      • 6.3.2 Pain Management

      • 6.3.3 Cardiovascular

      • 6.3.4 Other

    7 Transdermal Drug Delivery System Market: Regional Analysis

    • 7.1 Transdermal Drug Delivery System Regional Market Share Analysis, 2018 & 2026

    • 7.2 Transdermal Drug Delivery System Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Boehringer Ingelheim GmbH

      • 9.1.1 Boehringer Ingelheim GmbH Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Watson Pharmaceuticals, Inc

      • 9.2.1 Watson Pharmaceuticals, Inc Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 4P Therapeutics, LLC

      • 9.3.1 4P Therapeutics, LLC Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Biogel Technology, Inc

      • 9.4.1 Biogel Technology, Inc Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Mylan Pharmaceuticals, Inc

      • 9.5.1 Mylan Pharmaceuticals, Inc Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Noven Pharmaceuticals, Inc.

      • 9.6.1 Noven Pharmaceuticals, Inc. Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Johnson & Johnson

      • 9.7.1 Johnson & Johnson Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Novartis AG

      • 9.8.1 Novartis AG Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Transdermal Technologies, Inc

      • 9.9.1 Transdermal Technologies, Inc Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Transdermal Corp.

      • 9.10.1 Transdermal Corp. Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Echo Therapeutics, Inc

      • 9.11.1 Echo Therapeutics, Inc Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Skyepharma PLC

      • 9.12.1 Skyepharma PLC Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 3M Company

      • 9.13.1 3M Company Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

     

    The List of Tables and Figures (Totals 82 Figures and 144 Tables)

    • Figure Electroporation Transdermal Drug Delivery System market, 2015 - 2026 (USD Million)

    • Figure Radiofrequency Transdermal Drug Delivery System market, 2015 - 2026 (USD Million)

    • Figure Iontophoresis Transdermal Drug Delivery System market, 2015 - 2026 (USD Million)

    • Figure Microporation Transdermal Drug Delivery System market, 2015 - 2026 (USD Million)

    • Figure Other Transdermal Drug Delivery System market, 2015 - 2026 (USD Million)

    • Figure Central Nervous System (CNS) market, 2015 - 2026 (USD Million)

    • Figure Pain Management market, 2015 - 2026 (USD Million)

    • Figure Cardiovascular market, 2015 - 2026 (USD Million)

    • Figure Other market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Transdermal Drug Delivery System market, by country, 2015 - 2026 (USD Million)

    • Table North America Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table North America Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table North America Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table Canada Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table Canada Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Europe Transdermal Drug Delivery System market, by country, 2015 - 2026 (USD Million)

    • Table Europe Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table Europe Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table Europe Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table Germany Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table Germany Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table France Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table France Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table Italy Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table Italy Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table Spain Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table Spain Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Transdermal Drug Delivery System market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table China Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table China Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table Japan Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table Japan Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table India Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table India Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Transdermal Drug Delivery System market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table MEA Transdermal Drug Delivery System market, by country, 2015 - 2026 (USD Million)

    • Table MEA Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table MEA Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table MEA Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Transdermal Drug Delivery System market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Transdermal Drug Delivery System market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Transdermal Drug Delivery System market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Boehringer Ingelheim GmbH Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Watson Pharmaceuticals, Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table 4P Therapeutics, LLC Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Biogel Technology, Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Mylan Pharmaceuticals, Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Noven Pharmaceuticals, Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novartis AG Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Transdermal Technologies, Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Transdermal Corp. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Echo Therapeutics, Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Skyepharma PLC Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table 3M Company Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US